We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioventix Plc | LSE:BVXP | London | Ordinary Share | GB00B4QVDF07 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-25.00 | -0.56% | 4,450.00 | 4,400.00 | 4,500.00 | 4,475.00 | 4,450.00 | 4,475.00 | 464 | 09:25:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 12.82M | 8.37M | 1.6071 | 27.85 | 233.12M |
TIDMBVXP TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer Bioventix of existing shares to which voting rights are (Sedol attached: ii B4QVDF0) 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the CASTLEFIELD FUND PARTNERS LIMITED notification obligation: iii 4. Full name of shareholder(s) (if different from 3.):iv 5. Date of the transaction and date on 27th March 2017 which the threshold is crossed or reached: v 6. Date on which issuer notified: 3rd April 2017 7. Threshold(s) that is/are crossed or 6% reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after the triggering transaction shares to the triggering transaction if possible using Number Number Number Number of voting % of voting rights x the ISIN CODE of of of shares rights Shares Voting Rights Direct Direct xi Indirect Direct Indirect xii 300,000 300,000 320,000 320,000 6.276% GB00B4QVDF07 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights instrument price date xvii Conversion instrument refers to xix, xx period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 300,000 6.276% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: Percentage based on Issued Share Capital of 5,098,656 14. Contact name: Richard Vickers 15. Contact telephone number: 0161 233 4890 END
(END) Dow Jones Newswires
April 03, 2017 07:14 ET (11:14 GMT)
1 Year Bioventix Chart |
1 Month Bioventix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions